Brain volume changes in first-episode schizophrenia: A 1-year follow-up study

Archives of General Psychiatry

Volumn 59, Issue 11, 2002, Pages 1002-1010

  Doniger, Glen M ^a,b   Foxe, John J ^a,c   Murray, Micah M ^a   Higgins, Beth A ^a   Javitt, Daniel C ^a,d  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE; SULPIRIDE;

ADULT; ARTICLE; BRAIN SIZE; BRAIN THIRD VENTRICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; LATERAL BRAIN VENTRICLE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; TREATMENT OUTCOME; WHITE MATTER;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; DOMINANCE, CEREBRAL; ECHO-PLANAR IMAGING; FEMALE; FOLLOW-UP STUDIES; FOURIER ANALYSIS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0036840040     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.59.11.1002     Document Type: Article

References (84)

1. Wright IC, Rabe-Hesketh S, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry. 2000;157:16-25.
2. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia: A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry. 1998;172:110-120.
3. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res. 2001;49:1-52.
4. Pilowsky LS, Kerwin RW, Murray RM. Schizophrenia: A neurodevelopmental perspective. Neuropsychopharmacology. 1993;9:83-91.
5. Weinberger DR. On the plausibility of "the neurodevelopmental hypothesis" of schizophrenia. Neuropsychopharmacology. 1996;14:1S-11S.
6. Erlenmeyer-Kimling L. Neurobehavioral deficits in offspring of schizophrenic parents: Liability indicators and predictors of illness. Am J Med Genet. 2000;97:65-71.
7. Walker EF, Savoie T, Davis D. Neuromotor precursors of schizophrenia. Schizophr Bull. 1994;20:441-451.
8. Nasrallah HA, Olson SC, Jacoby CG. Cerebral ventricular enlargement in schizophrenia. Arch Gen Psychiatry. 1986;43:157-159.
9. Illowsky BP, Juliano DM, Weinberger DR. Stability of CT scan findings in schizophrenia: Results of an 8 year follow-up study. J Neurol Neurosurg Psychiatry. 1988;51:209-213.
10. Vita A, Sacchetti E, Cazzullo CL. Brain morphology in schizophrenia: A 2-to 5-year CT scan follow-up study. Acta Psychiatr Scand. 1988;78:618-621.
11. Sponheim SR, Iacono WG, Beiser M. Stability of ventricular size after the onset of psychosis in schizophrenia. Psychiatry Res. 1991;40:21-29.
12. Vita A, Giobbio GM, Dieci M, Garbarini M, Morganti C, Comazzi M, Invernizzi G. Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia. Biol Psychiatry. 1994;35:960-962.
13. Kemali D, Maj M, Salvati A. Ventricle to brain ratio in schizophrenia: A controlled follow-up study. Biol Psychiatry. 1989;26:753-756.
14. Degreef G, Ashtari M, Wu HW, Borenstein M, Geisler S, Lieberman J. Follow-up MRI study in first episode schizophrenia. Schizophr Res. 1991;5:204-206.
15. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, Shenton ME. MRI anatomy of schizophrenia. Biol Psychiatry. 1999;45:1099-1119.
16. Kraepelin E. Dementia PraecoxandParaphrenia. Edinburgh, Scotland: E & S Livingstone; 1919.
17. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 1997;74:129-140.
18. Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry. 1998;155:1661-1670.
19. Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry. 1999;46:729-739.
20. DeLisi LE. Defining the course of brain structural change and plasticity in schizophrenia. Psychiatry Res. 1999;92:1-9.
21. Fenton WS, McGlashan TH. Natural history of schizophrenia subtypes, II: Positive and negative symptoms and long-term course. Arch Gen Psychiatry. 1991;48:978-986.
22. van der Heiden W, Häfner H. The epidemiology of onset and course of schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2000;250:292-303.
23. Davidson L, McGlashan TH. The varied outcomes of schizophrenia. Can J Psychiatry. 1997;42:47-43.
24. DeLisi LE, Stritzke P, Riordan H, Holan V, Boccio A, Kushner M, McClelland J, Van Eyl O, Anand A. The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome [published erratum appears in Biol Psychiatry. 1992;31:1172]. Biol Psychiatry. 1992;31:241-254.
25. DeLisi LE, Tew W, Xie S, Hoff AL, Sakuma M, Kushner M, Lee G, Shedlack K, Smith AM, Grimson R. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: Preliminary findings. Biol Psychiatry. 1995;38:349-360.
26. Nair TR, Christensen JD, Kingsbury SJ, Kumar NG, Terry WM, Garver DL. Progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatry Res. 1997;74:141-150.
27. Rapoport JL, Giedd J, Kumra S, Jacobsen L, Smith A, Lee P, Nelson J, Hamburger S. Childhood-onset schizophrenia: Progressive ventricular change during adolescence. Arch Gen Psychiatry. 1997;54:897-903.
28. Jacobsen LK, Giedd JN, Castellanos FX, Vaituzis AC, Hamburger SD, Kumra S, Lenane MC, Rapoport JL. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am J Psychiatry. 1998;155:678-685.
29. Davis KL, Buchsbaum MS, Shihabuddin L, Spiegel-Cohen J, Metzger M, Frecska E, Keefe RS, Powchik P. Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry. 1998;43:783-793.
30. Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, Gur RC. A follow-up magnetic resonance imaging study of schizophrenia: Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry. 1998;55:145-152.
31. Keshavan MS, Haas GL, Kahn CE, Aguilar E, Dick EL, Schooler NR, Sweeney JA, Pettegrew JW. Superior temporal gyrus and the course of early schizophrenia: Progressive, static, or reversible? J Psychiatr Res. 1998;32:161-167.
32. Rapoport JL, Evans A. Progressive cortical change during adolescence in childhoodonset schizophrenia. Arch Gen Psychiatry. 1999;56:649-654.
33. Giedd JN, Jeffries NO, Rapoport JL. Childhood-onset schizophrenia: Progressive brain changes during adolescence. Biol Psychiatry. 1999;46:892-898.
34. Hirayasu Y, Shenton ME, McCarley RW. Progressive change in posterior superior temporal gyrus in schizophrenia [abstract]. Biol Psychiatry. 1999;45:117S.
35. Lieberman J, Chakos M, Wu H, Alvir J, Hoffman E, Robinson D, Bilder R. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry. 2001;49:487-499.
36. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: A longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 2001;58:148-157.
37. Madsen AL, Keidling N, Karie A, Esbjerg S, Hemmingsen R. Neuroleptics in progressive structural brain abnormalities in psychiatric illness [letter]. Lancet. 1998;352:784-785.
38. Madsen AL, Karle A, Rubin P, Cortsen M, Andersen HS, Hemmingsen R. Progressive atrophy of the frontal lobes in first-episode schizophrenia: Interaction with clinical course and neuroleptic treatment. Acta Psychiatr Scand. 1999;100:367-374.
39. Pfefferbaum A, Mathalon DH, Lim KO. A quantitative MRI study of changes in brain orphology from infancy to late adulthood. Arch Neurol. 1994;51:874-887.
40. Steen RG, Ogg RJ, Reddick WE, Kingsley PB. Age-related changes in the pediatric brain: Quantitative MR evidence of maturational changes during adolescence. AJNR Am J Neuroradiol. 1997;18:819-828.
41. Courchesne E, Chisum HJ, Press GA. Normal brain development and aging: Quantitative analysis at in vivo MRI in healthy volunteers. Radiology. 2000;216:672-682.
42. Jernigan TL, Archibald SL, Fennema-Notestine C, Gamst AC, Stout JC, Bonner J, Hesselink JR. Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol Aging. 2001;22:581-594.
43. Bartzokis G, Beckson M, Lu PH, Nuechterlein KH, Edwards N, Mintz J. Agerelated changes in frontal and temporal lobe volumes in men: A magnetic resonance imaging study. Arch Gen Psychiatry. 2001;58:461-465.
44. Andreasen NC, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH): An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry. 1992;49:615-623.
45. Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, van der Heiden W. IRAOS: An instrument for the assessment of onset and early course of schizophrenia. Schizophr Res. 1992;6:209-223.
46. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
47. Commissie Farmaceutische Hulp van het College voor Zorgverzekeringen. Farmacotherapeutisch Kompas [in Dutch]. Amstelveen, the Netherlands: Commissie Farmaceutische Hulp van het College voor Zorgverzekeringen; 2000.
48. Phelan M, Slade M, Hayward P. The Camberwell Assessment of Need: The validity and reliability of an instrument to assess the needs of people with severe mental illness. Br J Psychiatry. 1995;167:589-595.
49. Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Propositional System: An Approach to Cerebral Imaging. New York, NY: Thieme Medical Publishers; 1988.
50. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998;17:87-97.
51. Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P. Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging. 1997;16:187-198.
52. Schnack HG, Hulshoff Pol HE, Baare WF, Staal WG, Viergever MA, Kahn RS. Automated separation of gray and white matter from MR images of the human brain. Neuroimage. 2001;13:230-237.
53. Schnack HG, Hulshoff Pol HE, Baare WF, Viergever MA, Kahn RS. Automatic segmentation of the ventricular system from MR images of the human brain. Neuroimage. 2001;14:95-104.
54. Garver DL, Nair TR, Christensen JD, Holcomb JA, Kingsbury SJ. Brain and ventricle instability during psychotic episodes of the schizophrenias. Schizophr Res. 2000;44:11-23.
55. Huntley DA, Cho DW, Christman J, Csernansky JG. Predicting length of stay in an acute psychiatric hospital. Psychiatr Serv. 1998;49:1049-1053.
56. Olfson M, Mechanic D, Boyer CA, Hansell S, Walkup J, Weiden PJ. Assessing clinical predictions of early rehospitalization in schizophrenia. J Nerv Ment Dis. 1999;187:721-729.
57. Sytema S, Burgess P. Continuity of care and readmission in two service systems: A comparative Victorian and Groningen case-register study. Acta Psychiatr Scand. 1999;100:212-219.
58. Carpenter WT, Bartko JJ, Strauss JS, Hawk AB. Signs and symptoms as predictors of outcome: A report from the International Pilot Study of Schizophrenia, Am J Psychiatry. 1978;135:940-944.
59. Carpenter WT, Strauss JS. The prediction of outcome in schizophrenia, IV: Eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis. 1991;179:517-525.
60. Wijngaarden B, Schene AH, McCrone P. Caregiving in schizophrenia: Development, internal consistency and reliability of the involvement evaluation questionnaire (BES). Br J Psychiatry. 2000;177:S21-S27.
61. Lasalvia A, Ruggeri M, Mazzi MA, Dall'Agnola RB. The perception of needs for care in staff and patients in community-based mental health services. The South-Verona Outcome Project 3. Acta Psychiatr Scand. 2000;102:366-375.
62. Chakos MH, Lieberman JA, Alvir J, Bilder R, Ashtari M. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet. 1995;345:456-457.
63. Westmoreland P, Nopoulos P, Andreasen NC, Heckel D, Arndt S. Caudate size in first episode neuroleptic naive schizophrenia patients measuring using an artificial neural network. Soc Biol Psychiatry. 1999;46:712-720.
64. Scheepers FE, Gispen de Wied CC, Hulshoff Pol HE, Kahn RS. Effect of clozapine on caudate nucleus volume in relation to symptoms of schizophrenia. Am J Psychiatry. 2001;158:644-646.
65. Lim KO, Tew W, Kushner M, Chow K, Matsumoto B, DeLisi LE. Cortical gray matter volume deficit in patients with first-episode schizophrenia. Am J Psychiatry. 1996;153:1548-1553.
66. Zipursky RB, Lambe EK, Kapur S, Mikulis DJ. Cerebral gray matter volume deficits in first episode psychosis. Arch Gen Psychiatry. 1998;55:540-546.
67. Seidman LJ, Faraone SV, Goldstein JM, Goodman JM, Kremen WS, Toomey R, Tourville J, Kennedy D, Makris N, Caviness VS, Tsuang MT. Thalamic and amygdalahippocampal volume reductions in first-degree relatives of patients with schizophrenia: An MRI-based morphometric analysis. Biol Psychiatry. 1999;46:941-954.
68. Staal WG, Hulshoff Pol HE, Schnack HG, Hoogendoorn MLC, Kahn RS. Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am J Psychiatry. 2000;157:416-421.
69. Carpenter WT, Schooler NR, Wise SS, Goldman H, Goldstein MJ, Hogarty GE, Jeste D, Kane JM, Klerman GL, Liberman RP, Paul SM, Robinson DS, Spring B, Stahl SM, Tamminga CA. Treatment, services, and environmental factors. Schizophr Bull. 1988;14:427-437.
70. Häfner H, Löffler W, Maurer K, Hambrecht M, van der Heiden W. Depression, negative symptoms, social stagnation, and social decline in the early course of schizophrenia. Acta Psychiatr Scand. 1999;100:105-118.
71. Eaton WW, Bilker W, Haro JM, Herrman H, Mortensen PB, Freeman H, Burgess P. Long-term course of hospitalization for schizophrenia, part II: Change with passage of time. Schizophr Bull. 1992;18:229-241.
72. Eaton WW, Mortensen PB, Herrman H, Freeman H, Bilker W, Burgess P, Wooff K. Long-term course of hospitalization for schizophrenia, part I: Risk for rehospitalization. Schizophr Bull. 1992;18:217-228.
73. Harrison PJ. The neuropathology of schizophrenia: A critical review of the data and their interpretation. Brain. 1999;122(pt 4):593-624.
74. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 1995;52:998-1007.
75. McEwen BS, Magarinos AM. Stress effects on morphology and function of the hippocampus. Ann N Y Acad Sci. 1997;821:271-284.
76. Harrison PJ. The neuropathological effects of antipsychotic drugs. Schizophr Res. 1999;40:87-99.
77. Horton K, Forsyth CS, Sibtain N, Ball S, Bruton CJ, Royston MC, Roberts GW. Ubiquitination as a probe for neurodegeneration in the brain in schizophrenia: The prefrontal cortex. Psychiatry Res. 1993;48:145-152.
78. Margolis RL, Chuang DM, Post RM. Programmed cell death: Implications for neuropsychiatric disorders. Biol Psychiatry. 1994;35:946-956.
79. Vaux DL. Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci U S A. 1993;90:786-789.
80. Bredesen DE. Neural apoptosis. Ann Neurol 1995;38:839-851.
81. Noh JS, Kang HJ, Kim EY, Sohn S, Chung YK, Kim SU, Gwag BJ. Haloperidol-induced neuronal apoptosis: Role of p38 and c-Jun-NH(2)-terminal protein kinase. J Neurochem. 2000;75:2327-2334.
82. Feinberg I. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res. 1982;17:319-334.
83. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans AC, Rapoport JL. Brain development during childhood and adolescence: A longitudinal MRI study. Nat Neurosci. 1999;2:861-863.
84. Andreasen NC, Flaum M, Swayze V, O'Leary DS, Alliger R, Cohen G, Ehrhardt J, Yuh WT. Intelligence and brain structure in normal individuals. Am J Psychiatry. 1993;150:130-134.